These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 18804509)

  • 1. Mixed allele malaria vaccines: host protection and within-host selection.
    Barclay VC; Chan BH; Anders RF; Read AF
    Vaccine; 2008 Nov; 26(48):6099-107. PubMed ID: 18804509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.
    Burns JM; Flaherty PR; Nanavati P; Weidanz WP
    Infect Immun; 2004 Oct; 72(10):5605-12. PubMed ID: 15385457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunization.
    Xu H; Hodder AN; Yan H; Crewther PE; Anders RF; Good MF
    J Immunol; 2000 Jul; 165(1):389-96. PubMed ID: 10861076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolutionary consequences of blood-stage vaccination on the rodent malaria Plasmodium chabaudi.
    Barclay VC; Sim D; Chan BH; Nell LA; Rabaa MA; Bell AS; Anders RF; Read AF
    PLoS Biol; 2012; 10(7):e1001368. PubMed ID: 22870063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization against Plasmodium chabaudi malaria using combined formulations of apical membrane antigen-1 and merozoite surface protein-1.
    Burns JM; Flaherty PR; Romero MM; Weidanz WP
    Vaccine; 2003 May; 21(17-18):1843-52. PubMed ID: 12706668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
    Rainczuk A; Scorza T; Spithill TW; Smooker PM
    Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of merozoite surface protein 1 and apical membrane antigen 1 vaccine efficacies against Plasmodium chabaudi malaria based on prechallenge antibody responses.
    Lynch MM; Cernetich-Ott A; Weidanz WP; Burns JM
    Clin Vaccine Immunol; 2009 Mar; 16(3):293-302. PubMed ID: 19116303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes.
    Crewther PE; Matthew ML; Flegg RH; Anders RF
    Infect Immun; 1996 Aug; 64(8):3310-7. PubMed ID: 8757869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malaria vaccine.
    Khurana SK; Talib VH
    Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective efficacy of MSP4/5 against lethal Plasmodium chabaudi adami challenge is dependent on the type of DNA vaccine vector and vaccination protocol.
    Rainczuk A; Smooker PM; Kedzierski L; Black CG; Coppel RL; Spithill TW
    Vaccine; 2003 Jun; 21(21-22):3030-42. PubMed ID: 12798647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design.
    Amante FH; Crewther PE; Anders RF; Good MF
    J Immunol; 1997 Dec; 159(11):5535-44. PubMed ID: 9548494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation from phage display libraries of single chain variable fragment antibodies that recognize conformational epitopes in the malaria vaccine candidate, apical membrane antigen-1.
    Fu Y; Shearing LN; Haynes S; Crewther P; Tilley L; Anders RF; Foley M
    J Biol Chem; 1997 Oct; 272(41):25678-84. PubMed ID: 9325291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with different PfAMA1 alleles in sequence induces clonal imprint humoral responses that are similar to responses induced by the same alleles as a vaccine cocktail in rabbits.
    Kusi KA; Faber BW; van der Eijk M; Thomas AW; Kocken CH; Remarque EJ
    Malar J; 2011 Feb; 10():40. PubMed ID: 21320299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying variation in the potential for antibody-mediated apparent competition among nine genotypes of the rodent malaria parasite Plasmodium chabaudi.
    Fairlie-Clarke KJ; Allen JE; Read AF; Graham AL
    Infect Genet Evol; 2013 Dec; 20():270-5. PubMed ID: 24056014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct effect of Plasmodium vivax recombinant vaccine candidates AMA-1 and MSP-119 on the innate immune response.
    Bueno LL; Fujiwara RT; Soares IS; Braga EM
    Vaccine; 2008 Feb; 26(9):1204-13. PubMed ID: 18242795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi.
    Anders RF; Crewther PE; Edwards S; Margetts M; Matthew ML; Pollock B; Pye D
    Vaccine; 1998; 16(2-3):240-7. PubMed ID: 9607037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing malaria vaccines to circumvent antigen variability.
    Ouattara A; Barry AE; Dutta S; Remarque EJ; Beeson JG; Plowe CV
    Vaccine; 2015 Dec; 33(52):7506-12. PubMed ID: 26475447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Immunization With a Polymorphic Malaria Vaccine Candidate Induced Antibodies to Conserved Epitopes That Promote Functional Antibodies to Multiple Parasite Strains.
    Feng G; Boyle MJ; Cross N; Chan JA; Reiling L; Osier F; Stanisic DI; Mueller I; Anders RF; McCarthy JS; Richards JS; Beeson JG
    J Infect Dis; 2018 Jun; 218(1):35-43. PubMed ID: 29584918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP1
    Rocha MV; Françoso KS; Lima LC; Camargo TM; Machado RLD; Costa FTM; Rénia L; Nosten F; Russell B; Rodrigues MM; Soares IS
    Vaccine; 2017 Apr; 35(18):2463-2472. PubMed ID: 28341111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.